While the molecular mechanisms of depression are still not sufficiently understood, most of the currently prescribed antidepressant agents target the serotonergic system by blocking the SERT and putatively desensitizing the 5-HT1A autoreceptors while increasing postsynaptic 5-HT1A signaling14. Here, SLC6A4 is linked to major depressive disorder.